Related Experiment Video
Updated: May 5, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.8K
Pre-prostatic tissue removed in robotic assisted lymph node dissection for prostate cancer contains lymph nodes
J Blarer1, C Padevit, K Horton
1Department of Urology, Kantonsspital Winterthur, Winterthur, Switzerland.
Urology Annals
|December 7, 2013
Summary
Pre-prostatic tissue (PPT) can contain lymph nodes with metastases, impacting prostate cancer staging. Evaluating this tissue during pelvic lymph node dissection (PLND) may improve accuracy.
Area of Science:
- Urology
- Oncology
- Surgical Pathology
Background:
- Pelvic lymph node dissection (PLND) templates are debated.
- Accurate staging is crucial for prostate cancer management.
Purpose of the Study:
- To analyze pre-prostatic tissue (PPT) for lymph nodes and metastases.
- To inform the optimal template for pelvic lymph node dissection.
Main Methods:
- Histopathological evaluation of PPT from 80 robotic assisted radical prostatectomies (RARP) and 1 extended staging lymph node dissection.
- Retrospective analysis of clinical data and comparison with histopathological findings.
- Patients underwent either limited (lPLND) or extended (ePLND) lymph node dissection.
Main Results:
- Lymph nodes were identified in PPT in 12.5% of RARP patients and the staging ePLND patient.
- Metastases were found in PPT in one patient undergoing staging ePLND.
- No clinical differences were observed between patients with or without lymph nodes in PPT.
Conclusions:
- Pre-prostatic tissue may harbor lymph nodes containing metastases.
- Inclusion of PPT in histopathological evaluation can enhance prostate cancer staging accuracy.
